Trials / Completed
CompletedNCT02769650
Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
Clinical Significance of Stress-MRI Evaluation of Right Coronary Artery Chronic Total Occlusion Recanalization Efficacy in Patients With Coronary Artery Disease.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this study is that Stress-MRI is a clinically significant method of myocardial perfusion assessment after coronary angioplasty with stenting of right coronary artery (RCA) chronic total occlusion (CTO) is performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CTO coronary angioplasty | A standard endovascular procedure is carried out under local anesthesia and under fluoroscopic control. Recanalisation of coronary artery CTO is performed by the hydrophilic coronary wire, using the most appropriate technique. Then balloon angioplasty of target lesion is provided. After the angiographic control coronary stent is implanted. After coronary wire removing control angiographic study is provided. Medical therapy includes aspirin(acid acetylsalicylic) 125 - 300 mg/d and plavix(clopidogrel) in dose 300-600 mg prescription before the procedure and heparin (heparin sodium) injection during the procedure(5000 U iv). After the procedure aspirin(acid acetylsalicylic) in dose 100 mg/d within long period should be prescribed in all the patients, and plavix(clopidogrel) in dose 75/d should be prescribed within 12 months. |
| DRUG | Optimal medicamentous treatment | |
| PROCEDURE | Stress-MRI | A standard stress-MRI test with adenosine |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2016-05-11
- Last updated
- 2016-05-17
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02769650. Inclusion in this directory is not an endorsement.